Physiological Genomics

Aims & Scope

The Physiological Genomics publishes original papers, reviews and rapid reports in a wide area of research focused on uncovering the links between genes and physiology at all levels of biological organization.

Articles on topics ranging from single genes to the whole genome and their links to the physiology of humans, any model organism, organ, tissue or cell are welcome.

Areas of interest include complex polygenic traits preferably of importance to human health and gene-function relationships of disease processes.

Specifically, the Journal has dedicated Sections focused on genome-wide association studies (GWAS) to function, cardiovascular, renal, metabolic and neurological systems, exercise physiology, pharmacogenomics, clinical, translational and genomics for precision medicine, comparative and statistical genomics and databases.

For further details on research themes covered within these Sections, please refer to the descriptions given under each Section.

View Aims & Scope

---

Metrics & Ranking

Impact Factor

Year	Value
2025	2.5
2024	2.50

SJR (SCImago Journal Rank)

Year	Value
2024	0.911

Quartile

Year	Value
2024	Q2

h-index

Year	Value
2024	129

Journal Rank

Year	Value
2024	5599

Journal Citation Indicator

Year	Value
2024	371

---

---

Abstracting & Indexing

Journal is indexed in leading academic databases, ensuring global visibility and accessibility of our peer-reviewed research.

• Scopus
• Google Scholar
• Web of Science
• Medline
• Embase

---

Subjects & Keywords

Journal’s research areas, covering key disciplines and specialized sub-topics in Biochemistry, Genetics and Molecular Biology, designed to support cutting-edge academic discovery.

---

Most Cited Articles

The Most Cited Articles section features the journal's most impactful research, based on citation counts. These articles have been referenced frequently by other researchers, indicating their significant contribution to their respective fields.

• GAPDH as a housekeeping gene: analysis of GAPDH mRNA expression in a panel of 72 human tissues

  Citation: 623

  Authors: Robert D., Dan W., Robert A., Brian J.

• Life-long reduction in MnSOD activity results in increased DNA damage and higher incidence of cancer but does not accelerate aging

  Citation: 578

  Authors: Holly, Yuji, Michelle, Mohammad, Norman, Suzanne R., Nathan L., John W., Charles J., Ting-Ting, James, Randy, Arlan

• Altered microRNA expression in human heart disease

  Citation: 509

  Authors: Sadakatsu, Sek Won, Jun, Egbert, Hao, Paul D., Todd R., Burkert, William T.

• Artificial intelligence and machine learning to fight COVID-19

  Citation: 433

  Authors: Ahmad, Sachin, Ishan, Patricia B., Bina, Xi

• The miR-29 family: genomics, cell biology, and relevance to renal and cardiovascular injury

  Citation: 424

  Authors: Alison J., Yong, Yi, Xiaoqiang, Mingyu

• Comparison of human adult and fetal expression and identification of 535 housekeeping/maintenance genes

  Citation: 383

  Authors: JANET A., ARCHANA, MAMATHA, MAYA

• Nrf2 at the heart of oxidative stress and cardiac protection

  Citation: 383

  Authors: Qin M., Anthony J.

• Microbial short chain fatty acid metabolites lower blood pressure via endothelial G protein-coupled receptor 41

  Citation: 367

  Authors: Niranjana, Daijiro, Sheila, Jochen, Nicholas A., Dan E., Jennifer L.

• A metabolomic comparison of urinary changes in type 2 diabetes in mouse, rat, and human

  Citation: 353

  Authors: R. M., M. L., E., D. V., T., M., D., B. C., J. N., R. D., S. C., J. L.

• The COVID-19 pandemic: a global health crisis

  Citation: 352

  Authors: Casey A., Michael P., Andrea L.

---